Fate Therapeutics Price Chart
Fate Therapeutics Volume Chart
Fate Therapeutics Market Segments
After Hours
-0.02(-1.46%)
| Open | $1.37 |
|---|---|
| Close | $1.35 |
| Low | $1.35 |
| Low Change | -0.02 (-1.46%) |
| High | $1.37 |
| High Change | +0.00 (+0.00%) |
| Range | $0.02 |
| Volume | 2.211K |
| Dollar Volume | $2.98K |
Regular Trading Hours
-0.09(-5.86%)
| Open | $1.45 |
|---|---|
| Close | $1.37 |
| Low | $1.33 |
| Low Change | -0.12 (-8.14%) |
| High | $1.45 |
| High Change | +0.00 (+0.00%) |
| Range | $0.12 |
| Volume | 1.372M |
| Dollar Volume | $1.87M |
Premarket
+0.00(+0.00%)
| Open | $1.49 |
|---|---|
| Close | $1.49 |
| Low | $1.49 |
| Low Change | 0.00 (0.00%) |
| High | $1.49 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 955 |
| Dollar Volume | $1.42K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.08(+5.67%)
| Open | $1.41 |
|---|---|
| Close | $1.49 |
| Low | $1.41 |
| Low Change | 0.00 (0.00%) |
| High | $1.52 |
| High Change | +0.11 (+7.45%) |
| Range | $0.11 |
| Volume | 1.062M |
| Dollar Volume | $1.58M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $1.41 |
|---|---|
| Close | $1.41 |
| Low | $1.41 |
| Low Change | 0.00 (0.00%) |
| High | $1.43 |
| High Change | +0.02 (+1.42%) |
| Range | $0.02 |
| Volume | 7.621K |
| Dollar Volume | $10.75K |
Fate Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.53 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.47 |
| 20 Day Moving Average (SMA20) | $1.31 |
| 50 Day Moving Average (SMA50) | $1.18 |
| 100 Day Moving Average (SMA100) | $1.21 |
| 200 Day Moving Average (SMA200) | $1.17 |
Fate Therapeutics Statistics
| Average Volume (30 Days) | 1.83M |
|---|---|
| P/E Ratio (Current) | -1.10 |
| EPS (Current) | -$1.35 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$115.43M |
| Cash Ratio | 1.45 |
| Current Ratio | 7.87 |
| Quick Ratio | 7.87 |
| Debt to Equity | 0.00 |
| Enterprise Value | $130.10M |
| EV to EBITDA | -0.90 |
| EV to Sales | 18.23 |
| Price to Book | 0.73 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 23.92 |
| Return on Assets | -0.45% |
| Return on Equity | -0.67% |
Fate Therapeutics Stock Splits
There have been no stock splits for Fate Therapeutics (FATE).